Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation
Status:
Completed
Trial end date:
2017-03-16
Target enrollment:
Participant gender:
Summary
This trial will evaluate the comparative clinical effectiveness of pharmacopuncture for
severe non-acute sciatic pain patients diagnosed with lumbar disc herniation (LDH) with usual
care of conventional medicine and that of Korean medicine (acupuncture). Sixty patients with
severe non-acute sciatic pain patients diagnosed with LDH (NRS ≥5, 4 weeks - 6 months) will
be recruited, and randomized 20 each to the Shinbaro pharmacopuncture, acupuncture, and usual
care group, respectively. The 2 acupuncture groups will receive 2 sessions/week of
acupuncture alone or with pharmacopuncture for 4 weeks, and the usual care group will receive
conventional medication 2 times/day and 2 sessions/week of physical therapy. Post-treatment
evaluations will take place 5, 7, 9, and 12 weeks after randomization.